Zhihua Xu

Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.

L. Ren, Jianwei Wang, N. Xiong, 2020, JAMA.

Recombinant Super-Compound Interferon (rSIFN-co) Versus Interferon Alfa in the Treatment of Moderate-to-Severe COVID-19: A Multicentre, Randomised, Phase 2 Trial

Zheng-Yang Shi, N. Xiong, F. Luo, 2020 .

A novel cold-regulated protein isolated from Saussurea involucrata confers cold and drought tolerance in transgenic tobacco (Nicotiana tabacum).

Li Zhang, Jianbo Zhu, Zhihua Xu, 2019, Plant science : an international journal of experimental plant biology.

Meta-analysis of procalcitonin as a predictor for acute kidney injury

Yuan Li, D. Liao, Zhihua Xu, 2021, Medicine.

Dexmedetomidine Attenuates Renal and Myocardial Ischemia/Reperfusion Injury in a Dose-Dependent Manner by Inhibiting Inflammatory Response.

Qiu Chen, Zhihua Xu, Han Jiang, 2016, Annals of clinical and laboratory science.

Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial

Zheng-Yang Shi, N. Xiong, Wei-min Li, 2021, Annals of medicine.

Engineered interferon alpha effectively improves clinical outcomes of COVID-19 patients

Dan Liu, Zheng-Yang Shi, N. Xiong, 2020 .

Ischaemic colitis during pegylated interferon-alpha monotherapy for chronic hepatitis B: A case report

Zhihua Xu, Hui Chen, Yu Liu, 2022, Medicine.